Hemodynamic effects of platelet activating factor in the dog kidney in vivo
- PMID: 3744467
- DOI: 10.1161/01.hyp.8.9.737
Hemodynamic effects of platelet activating factor in the dog kidney in vivo
Abstract
The effect of platelet activating factor (PAF) on renal hemodynamics and function was examined in anesthetized dogs. The infusion of PAF into the renal artery at 5, 10, and 20 ng X min-1 X kg-1 body weight resulted in dose-dependent reductions in renal blood flow, glomerular filtration rate, urine volume, and urinary sodium excretion, whereas the infusion of vehicle alone in the contralateral kidney did not result in significant changes in these parameters. The maximum decrease expressed as the percent change from baseline was 22.2 +/- 1.7% for renal blood flow, 50.8 +/- 11% for glomerular filtration rate, 67.3 +/- 4.2% for urine volume, and 69.0 +/- 8.5% for urinary sodium excretion, respectively. These renal effects were not accompanied by significant alterations in systemic arterial blood pressure and heart rate. Pretreatment with indomethacin to block prostaglandin synthesis enhanced the effect of PAF on kidney function. Our data demonstrate that, unlike the rat kidney, intrarenal PAF infusion into the intact dog results in vasoconstriction and serve reduction in glomerular filtration rate.
Similar articles
-
Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655,240, a new thromboxane-prostaglandin endoperoxide antagonist.Can J Physiol Pharmacol. 1989 Apr;67(4):304-8. doi: 10.1139/y89-049. Can J Physiol Pharmacol. 1989. PMID: 2758373
-
Hemodynamic effects of PAF-acether on the dog kidney.Prostaglandins Leukot Med. 1987 Mar;26(3):189-202. doi: 10.1016/0262-1746(87)90029-1. Prostaglandins Leukot Med. 1987. PMID: 3033688
-
Thromboxane mediates the renal hemodynamic effects of platelet activating factor.J Pharmacol Exp Ther. 1990 May;253(2):743-8. J Pharmacol Exp Ther. 1990. PMID: 2140130
-
What does the renal reserve mean?Kidney Int. 1994 Feb;45(2):411-6. doi: 10.1038/ki.1994.53. Kidney Int. 1994. PMID: 8164427 Review. No abstract available.
-
Atypical Renal Clearance of Nanoparticles Larger Than the Kidney Filtration Threshold.Int J Mol Sci. 2021 Oct 17;22(20):11182. doi: 10.3390/ijms222011182. Int J Mol Sci. 2021. PMID: 34681853 Free PMC article. Review.
Cited by
-
Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.Br J Pharmacol. 1993 Dec;110(4):1347-52. doi: 10.1111/j.1476-5381.1993.tb13967.x. Br J Pharmacol. 1993. PMID: 8306074 Free PMC article.
-
Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.J Clin Invest. 1993 Apr;91(4):1374-9. doi: 10.1172/JCI116339. J Clin Invest. 1993. PMID: 8473488 Free PMC article.
-
Protection of platelet-activating factor-induced acute renal failure by BN 52021.Br J Exp Pathol. 1988 Apr;69(2):291-9. Br J Exp Pathol. 1988. PMID: 3377967 Free PMC article.
-
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.Br J Pharmacol. 1991 Dec;104(4):797-804. doi: 10.1111/j.1476-5381.1991.tb12509.x. Br J Pharmacol. 1991. PMID: 1667286 Free PMC article.
-
Platelet-activating factor in cardiovascular stress situations.Lipids. 1991 Dec;26(12):1257-63. doi: 10.1007/BF02536543. Lipids. 1991. PMID: 1819713 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous